UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
AMERICAN BIOGENETIC SCIENCES, INC.
-------------------------------------------------
(Name of Issuer)
CLASS A COMMON STOCK, $.001 par value per share
-------------------------------------------------
(Title of Class of Securities)
024611 10 5
-----------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with the statement [_]. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
13G
- ---------------------- -----------------
CUSIP No. 024611 10 5 Page 2 of 5 Pages
- ---------------------- -----------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
ALFRED J. ROACH
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
3,050,500
--------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH --------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 3,050,500
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,050,500
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
16.2%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ---------------------- -----------------
CUSIP No. 024611 10 5 Page 3 of 5 Pages
- ---------------------- -----------------
Item 1(a) Name of Issuer:
AMERICAN BIOGENETIC SCIENCES, INC.
Item 1(b) Address of Issuer's Principal Executive Offices:
1375 Akron Street
Copiague, New York 11726
Item 2(a) Name of Person Filing:
Alfred J. Roach
Item 2(b) Address of Principal Business Office or, if none, Residence:
1375 Akron Street
Copiague, NY 11726
Item 2(c) Citizenship:
United States of America.
Item 2(d) Title of Class of Securities:
Common Stock, $.001 par value per share
Item 2(e) CUSIP Number:
024611 10 5
Item 3 Statements filed pursuant to Rule 13d-1(b) or 13d-2(b)
Not Applicable
Item 4 Ownership of Securities:
The following information is as at December 31, 1996:
(a) Amount Beneficially Owned: 3,050,500
Consists of (i) 548,750 shares of Class A Common Stock; (ii)
1,375,500 shares of Class A Common Stock issuable upon
conversion of the same number of shares of the Company's
Class B Common Stock, $.001 par value ("Class B Common
Stock"), each of which is convertible into
<PAGE>
- ---------------------- -----------------
CUSIP No. 024611 10 5 Page 4 of 5 Pages
- ---------------------- -----------------
one share of Class A Common Stock; (iii) 1,126,250 shares
of Class A Common Stock which are not outstanding but which
are subject to issuance upon exercise of the portion of
options which were exercisable on, or which become
exercisable within sixty days of, December 31, 1996,
granted to Mr. Roach under the Company's Stock Option Plan
(the "Options"). Each share of Class B Common Stock is
entitled to ten times the number of votes of each share of
Class A Common Stock.
(b) Percent of Class: 16.2%
Based on 16,270,994 shares of Class A Common Stock
outstanding on December 31, 1996 and assuming conversion of
all shares of Class B Common Stock beneficially owned by Mr.
Roach and the execise of the Options.
(c) Number of shares to which such person has:
(i) sole power to vote or to direct the vote - 3,050,500
(ii) shared power to vote or to direct the vote - 0
(iii) sole power to dispose or to direct the disposition
of - 3,050,500
(iv) shared power to dispose or to direct the disposition
of - 0
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
Not applicable
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company:
Not Applicable.
Item 8 Identification and Classification of Members of the Group:
Not Applicable.
<PAGE>
- ---------------------- -----------------
CUSIP No. 024611 10 5 Page 5 of 5 Pages
- ---------------------- -----------------
Item 9 Notice of Dissolution of Group:
Not Applicable.
Item 10 Certification:
Not Applicable.
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
Dated: February 14, 1997
/s/ Alfred J. Roach
-------------------------------
Alfred J. Roach
